Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 07, 2020 07:30 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Fiscal Third Quarter 2020 Operating Results – Best Quarter in Company History – Raises Full Year Guidance

CINCINNATI, Aug. 07, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fiscal third quarter ended June 30, 2020. Third Quarter Fiscal...
July 28, 2020 09:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces New Board Member - Anthony Bihl

CINCINNATI, July 28, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announces the appointment of Anthony Bihl III to its Board of Directors, effective immediately. “We welcome...
July 16, 2020 09:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Hold Third Quarter 2020 Financial Results Conference Call on August 7, 2020

CINCINNATI, July 16, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, will report third quarter 2020...
July 13, 2020 13:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces the Launch of a High-Sensitivity SARS-CoV-2 Nucleocapsid Antibody Pair for the Development of Rapid COVID-19 Antigen Assays

CINCINNATI, July 13, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that it has...
May 29, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience to Participate in the 40th Annual William Blair Growth Stock Conference

CINCINNATI, May 29, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) announced today that Jack Kenny, Chief Executive Officer, and Bryan Baldasare, Executive Vice President and...
May 26, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces It Will Supply Reagents for the Manufacturing of Tens of Millions of COVID-19 Antibody Tests Per Month

CINCINNATI, May 26, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, announced today that its...
May 20, 2020 16:20 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Promotes Tony Serafini-Lamanna to Executive Vice President of Diagnostics

CINCINNATI, May 20, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc.’s (NASDAQ: VIVO) Board of Directors announced that Tony Serafini-Lamanna has been promoted to Executive Vice President of...
May 08, 2020 07:30 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Second Quarter 2020 Operating Results; Raises Guidance on Strength of COVID-19 Related Products

CINCINNATI, May 08, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the second quarter ended March 31, 2020. Second Quarter Fiscal 2020...
May 06, 2020 08:00 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Partners with QuantuMDx on COVID-19 Assay

CINCINNATI, May 06, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a leading provider of diagnostic testing solutions and life science raw materials, is pleased to announce its...
April 30, 2020 10:50 ET | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces Closing of Transaction to Acquire Exalenz Bioscience

CINCINNATI, April 30, 2020 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO), a provider of diagnostic testing solutions and life science raw materials, has completed its previously...